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Metabolomics is the comprehensive analysis of small molecules in a biological 
system and has generated great interest for identifying novel biomarkers for disease 
diagnosis and pharmaceutical treatment.  Metabolomics has been used to identify citrate 
and choline as biomarkers for prostate and breast cancer, respectively.  In fact, both tests 
are now clinically available and supported by most health insurance providers.1, 2   
Metabolites are the end-products of cellular processes, and their levels can be 
regarded as the ultimate response of biological systems to genotype, phenotype, and 
environmental conditions.  They encompass a diverse group of low-molecular weight 
compounds including lipids, amino acids, peptides, nucleic acids, organic acids, vitamins, 
thiols, and carbohydrates,3 and are commonly analyzed using nuclear magnetic resonance 
spectroscopy, liquid chromatography/mass spectrometry, and/or gas 
chromatography/mass spectrometry.     
Metabolomics may be well suited for osteoarthritis (OA) research for many 
reasons including the tremendous heterogeneity in the disease process and recognition 
that no single bbiomarker can reflect the breadth of temporal and pathological processes 
associated with OA.4  Combining several biomarkers into a panel will assuredly increase 
the discriminatory capability5, as would occur with metabolic profiling.  Secondly, since 
metabolic perturbations are real-time, they indicate the current disease state, a distinct 
advantage over current clinical diagnostics and disease monitoring techniques for OA, 
such as radiography. 
Metabolomics has been employed to detect metabolic perturbations in urine, 
blood, synovium, and synovial fluid (SF) of animal models and patients with OA.  
Lamers and co-workers6 used nuclear magnetic resonance to study the urine from guinea 
pigs that spontaneously develop OA.  Disturbances in lactic acid, malic acid, 
hypoxanthine and alanine were found to contribute heavily to the metabolic profile of 
OA.  These investigators further studied the urine of humans with and without OA and 
found distinct patterns in the NMR spectra that could discriminate between groups.4  Zhai 
and co-workers7 employed metabolomics on human serum in a study of patients with and 
without knee OA.  The investigators demonstrated that the ratios of valine and leucine to 
histidine were predictive of OA, pointing towards interest in the use of branched-chain 
amino acids (BCAA) as potential biomarkers.7  Many of these studies of venous plasma 
or urine identify metabolites that may be related to aging, altered muscle mass, and other 
factors that may confound the unique signature of a pathological OA joint.  For these 
reasons, SF may yield the most accurate, real-time, and joint-specific metabolic profile. 
Metabolomics has been performed on SF from experimentally induced OA in 
canine knee joints.8  The nuclear magnetic resonance spectra demonstrated increased 
concentrations of lactate, pyruvate, glycerol, alanine, isoleucine, hydroxybutyrate, 
hydroxyisobutyrate, and lipoprotein associated fatty acids.  The investigators concluded 
that the intra-articular environment of OA was more hypoxic and acidotic than in the 
normal joint, and that arthritic joints may rely in part upon altered lipid metabolic 
pathways. 
 We have performed metabolomics on both human synovium and SF.  In our first 
study, the metabolic profile of conditioned media collected from synovium explant 
cultures was obtained for tissues from patients undergoing total knee arthroplasty (end-
stage OA) and from patients undergoing ligament or meniscal repair with little or no 
evidence of OA.9  Thirteen metabolites were significantly elevated in the end-stage OA 
group and included glutamine, succinate, pro-hydroxyproline, amongst others.  Despite 
results suggestive of a distinct metabolic profile in OA, the synovium culture method 
does not easily translate into clinical practice. 
 In a second study, we performed metabolomics on ankle SF of patients with and 
without ankle OA.10  Results identified 106 metabolites as significantly elevated in the 
OA samples and represented perturbations in virtually all metabolic pathways, including 
amino acid metabolism, carbohydrate metabolism, mitochondrial oxidation, lipid 
metabolism, peptide, vitamin, and nucleotide synthesis, and redox homeostasis.  More 
importantly, when a rigorous decision tree analysis was applied to the metabolic profiles 
of the two populations, a 90% discriminatory accuracy was achieved, indicating the 
potential use of this technology as a diagnostic tool for OA.  Studies are ongoing to 
confirm these findings in a larger population and to generate a narrowed panel of 
metabolic biomarkers and measurement methods for translation into the clinic. 
 In conclusion, metabolic profiling of biofluids and tissues can provide a 
panoramic view of the current physiologic state of a biological system such as the intra-
articular environment of an osteoarthritic joint.  We envision the role of metabolomics for 
OA as a clinically applied diagnostic tool in which a sample of a patient’s synovial fluid 
would be analyzed for a panel of metabolite biomarkers, similar to following serial values 
from a complete blood count.  Alterations in the metabolic profile could indicate disease 
progression or a therapeutic response at a resolution not possible with currently employed 
clinical techniques. 
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